UB Paderborn / Katalog / Suche / in CDI

Microscopic analysis of the influence of ratcheting on the evolution of dislocation structures observed in AISI 316L stainless steel during low cycle fatigue

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 2013-12, Vol.587, p.1-11

2013

Volltextzugriff (PDF)

Cyclic mechanical behavior of 316L: Uniaxial LCF and strain-controlled ratcheting tests

Nuclear engineering and design, 2013-04, Vol.257, p.100-108

2013

Volltextzugriff (PDF)

Multiaxial fatigue behavior of AISI 316L subjected to strain-controlled and ratcheting paths

International journal of fatigue, 2014, Vol.68, p.195-208

2014

Volltextzugriff (PDF)

An internal variable dependent constitutive cyclic plastic material description including ratcheting calibrated for AISI 316L

Computational materials science, 2014-05, Vol.87, p.160-171

2014

Volltextzugriff (PDF)

PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC

Radiotherapy and oncology, 2023-05, Vol.182, p.S811-S811

2023

Volltextzugriff (PDF)

167P Five-years incidence of SCLC and analysis of PM2.5 air pollution in the province of Brescia: Preliminary results

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S132

2023

Volltextzugriff (PDF)

PO-2100 Radiomic features and PFS post-PACIFIC in the Blue Sky Observational Study on stage 3 PDL1+ NSCLC

Radiotherapy and oncology, 2023-05, Vol.182, p.S1883-S1884

2023

Volltextzugriff (PDF)

123P Second progression-free survival (PFS2) after first progression in patients receiving PACIFIC regimen: An exploratory analysis of the Blue Sky observational study

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S110

2023

Volltextzugriff (PDF)

PO-1086 Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes

Radiotherapy and oncology, 2022-05, Vol.170, p.S920-S922

2022

Volltextzugriff (PDF)

PO-1037 Hypofractionated Radiation Therapy For Non-Elderly Patients With Glioblastoma

Radiotherapy and oncology, 2021-08, Vol.161, p.S864-S865

2021

Volltextzugriff (PDF)

BLUE SKY STUDY: RADIOMICS FEATURES AS PREDICTIVE MARKERS OF PROGRESSION-FREE SURVIVAL IN STAGE III, PD-L1 POSITIVE NSCLC

Physica medica, 2023-11, Vol.115, p.102871, Article 102871

2023

Volltextzugriff (PDF)

Spin Density Wave versus Fractional Magnetization Plateau in a Triangular Antiferromagnet

Physical review letters, 2022-08, Vol.129 (8), p.087201-087201, Article 087201

2022

Volltextzugriff (PDF)

Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population

The Journal of dermatological treatment, 2022-04, Vol.33 (3), p.1638-1642

2022

Volltextzugriff (PDF)

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

Movement disorders, 2018-07, Vol.33 (6), p.928-936

2018

Volltextzugriff (PDF)

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Lancet neurology, 2022-12, Vol.21 (12), p.1099-1109

2022

Volltextzugriff (PDF)

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

Annals of neurology, 2021-07, Vol.90 (1), p.52-61

2021

Volltextzugriff (PDF)

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

Acta dermato-venereologica, 2021-11, Vol.101 (11), p.adv00605-adv00605

2021

Volltextzugriff (PDF)

Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology?

The Journal of dermatological treatment, 2022-01, Vol.33 (1), p.597-598

2022

Volltextzugriff (PDF)

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and therapy, 2023-12, Vol.12 (6), p.1937-1958

2023

Volltextzugriff (PDF)

Consistency test of precipitating ice cloud retrieval properties obtained from the observations of different instruments operating at Dome C (Antarctica)

Atmospheric measurement techniques, 2022-12, Vol.15 (24), p.7235-7258

2022

Volltextzugriff (PDF)

Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital

International journal of dermatology, 2021-07, Vol.60 (7), p.860-863

2021

Volltextzugriff (PDF)

Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report

Journal of clinical immunology, 2020-10, Vol.40 (7), p.1038-1040

2020

Volltextzugriff (PDF)

Brodalumab: A new way to inhibit IL‐17 in psoriasis

Dermatologic therapy, 2020-05, Vol.33 (3), p.e13403-n/a

2020

Volltextzugriff (PDF)

1187 Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, reduces immune biomarkers in active lesions and increases melanocyte products in stable lesions in patients with non-segmental vitiligo (NSV)

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S204-S204

2023

Volltextzugriff (PDF)

Proteomic characterization of atopic dermatitis blood from infancy to adulthood

Journal of the American Academy of Dermatology, 2023-05, Vol.88 (5), p.1083-1093

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Microscopic analysis of the influence of ratcheting on the evolution of dislocation structures observed in AISI 316L stainless steel during low cycle fatigue

Cyclic mechanical behavior of 316L: Uniaxial LCF and strain-controlled ratcheting tests

Multiaxial fatigue behavior of AISI 316L subjected to strain-controlled and ratcheting paths

An internal variable dependent constitutive cyclic plastic material description including ratcheting calibrated for AISI 316L

PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC

167P Five-years incidence of SCLC and analysis of PM2.5 air pollution in the province of Brescia: Preliminary results

PO-2100 Radiomic features and PFS post-PACIFIC in the Blue Sky Observational Study on stage 3 PDL1+ NSCLC

123P Second progression-free survival (PFS2) after first progression in patients receiving PACIFIC regimen: An exploratory analysis of the Blue Sky observational study

PO-1086 Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes

PO-1037 Hypofractionated Radiation Therapy For Non-Elderly Patients With Glioblastoma

BLUE SKY STUDY: RADIOMICS FEATURES AS PREDICTIVE MARKERS OF PROGRESSION-FREE SURVIVAL IN STAGE III, PD-L1 POSITIVE NSCLC

Spin Density Wave versus Fractional Magnetization Plateau in a Triangular Antiferromagnet

Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology?

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Consistency test of precipitating ice cloud retrieval properties obtained from the observations of different instruments operating at Dome C (Antarctica)

Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital

Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report

Brodalumab: A new way to inhibit IL‐17 in psoriasis

1187 Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, reduces immune biomarkers in active lesions and increases melanocyte products in stable lesions in patients with non-segmental vitiligo (NSV)

Proteomic characterization of atopic dermatitis blood from infancy to adulthood

Suchergebnisse filtern